GI Windows Flexagon Plus OTOLoc System
GI Windows Surgical · Decision date Oct 28, 2026
What did the FDA decide?
The FDA recorded a substantially equivalent (SESE) decision on 2026-10-28 for the GI Windows Flexagon Plus OTOLoc System, submitted by GI Windows Surgical of Canton, Massachusetts. The submission is K261630, a traditional 510(k) received on 05/18/2026 and handled under product code SAH within the General and Plastic Surgery specialty and review panel. The public record lists the device classification name as Magnetic Compression Anastomosis System.
SESE means the submission was cleared as substantially equivalent to a legally marketed predicate device; it is not a PMA approval. The record shows no third-party review, no combination product designation and no authorized predetermined change control plan. The reviewed documents do not identify the predicate device, the specific components or changes assessed, or the basis for the equivalence finding, so those details remain unknown from this source.
The page was last updated 11/02/2026. No clinical performance data, indications for use or labeling content appear in the available excerpts, and none should be inferred from the clearance decision alone.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- General, Plastic Surgery
- Decision date
- Oct 28, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261630
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- GI Windows Surgical
- Product code
- SAH
- Decision code
- SESE
- Decision date
- Oct 28, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Magnetic Compression Anastomosis System.
- Applicant
- GI Windows Surgical
- Product code
- SAH
- FDA device class
- 2
FDA decision timeline
K261630 received
Application receipt date recorded by FDA.
K261630 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code SAH
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Gt Metabolic Solutions, Inc. | 510(k) clearance | Sep 16, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
GI Windows Surgical
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Canton, MA
Sources and methodology
- Original FDA record: K261630
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records